Additional file 1: Table S1. of The impact of direct-to-consumer personal genomic testing on perceived risk of breast, prostate, colorectal, and lung cancer: findings from the PGen study

SNPs included in commercial personal genomic testing panels for cancer risk assessment in July 2012. Table S2. Distribution of genetic risk estimates returned to 23andMe customers in the PGen Study. Table S3. Distribution of genetic risk estimates returned to Pathway Genomics customers in the PGen Study. Table S4. Sensitivity analyses: characterization of the outcome. Table S5. Sensitivity analyses: characterization of genetic risk results. Table S6. Sensitivity analyses: screening behaviors and missing data. (PDF 461Â kb